SCHEMBL23130183

SCHEMBL23130183

CCCCOC(=O)c1cccc2c1OB[C@@H](NC(=O)Cc1ccncc1)C2

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.40
▸ L3MBTL1 Q9Y468 3/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ TRPA1 O75762 2/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ TP53 P04637 1/20 0.37
▸ HSD17B10 Q99714 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ ADRA1D P25100 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ ADRA1B P35368 1/20 0.36
▸ DDX3X O00571 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23130105 0.84 TSHR (0.36) TSHRL3MBTL1TDP1TRPA1ALDH1A1
SCHEMBL23129910 0.83 TSHR (0.40) TSHRL3MBTL1TDP1TRPA1ALDH1A1
SCHEMBL23837605 0.83 TSHR (0.40) TSHRL3MBTL1TDP1TRPA1ALDH1A1
SCHEMBL23129889 0.82 ALDH1A1 (0.43) TSHRL3MBTL1TDP1ALDH1A1CYP3A4
SCHEMBL17337306 0.81 TSHR (0.39) TSHRL3MBTL1TDP1TRPA1ALDH1A1
SCHEMBL17337303 0.81 TSHR (0.39) TSHRL3MBTL1TDP1TRPA1ALDH1A1
SCHEMBL23837423 0.81 TRPA1 (0.37) TSHRL3MBTL1TDP1TRPA1ALDH1A1
SCHEMBL23130008 0.79 TSHR (0.39) TSHRL3MBTL1TDP1TRPA1ALDH1A1
SCHEMBL23837522 0.79 TSHR (0.40) TSHRL3MBTL1TDP1TRPA1ALDH1A1
SCHEMBL18966770 0.76 MTNR1A (0.36) TSHRL3MBTL1TDP1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154989-B1 BETA-LACTAMASE INHIBITORS VENATORX PHARMACEUTICALS INC (US) 2021-03-24 — — EP disclosed
Send feedback